Cited by 505Statistical Methods in Clinical TrialsAdvanced Causal Inference TechniquesMeta-analysis and systematic reviews

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal

Open access

Kent, David M, Rothwell, Peter M, Ioannidis, John PA, Altman, Doug G, Hayward, Rodney A·2010·Trials

DOI 10.1186/1745-6215-11-85PMC PMC2928211

Open this paper in CoChat — free account Open PDF

Abstract

Mounting evidence suggests that there is frequently considerable variation in the risk of the outcome of interest in clinical trial populations. These differences in risk will often cause clinically important heterogeneity in treatment effects (HTE) across the trial population, such that the balance between treatment risks and benefits may differ substantially between large identifiable patient subgroups; the "average" benefit observed in the summary result may even be non-representative of the treatment effect for a typical patient in the trial. Conventional subgroup analyses, which examine whether specific patient characteristics modify the effects of treatment, are usually unable to detect even large variations in treatment benefit (and harm) across risk groups because they do not account for the fact that patients have multiple characteristics simultaneously that affect the likelihood of treatment benefit. Based upon recent evidence on optimal statistical approaches to assessing HTE, we propose a framework that prioritizes the analysis and reporting of multivariate risk-based HTE and suggests that other subgroup analyses should be explicitly labeled either as primary subgroup analyses (well-motivated by prior evidence and intended to produce clinically actionable results) or secondary (exploratory) subgroup analyses (performed to inform future research). A standardized and transparent approach to HTE assessment and reporting could substantially improve clinical trial utility and interpretability.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/1745-6215-11-85

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020124 · Cited by 10,505
Self-citation
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · CHANCE · doi:10.1080/09332480.2005.10722754 · Cited by 4,702 · cited 1×
“Additionally, because conventional subgroup analyses involve multiple comparisons and involve splitting the overall sample to smaller sub-samples, they are both under-powered for detecting genuine subgroup effects (prone to false-negatives), and even more commonly they are prone to false positive findings [25-31].”
BackgroundSelf-citation
The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
Antman, E. M., Cohen, M. C., Bernink, P. J. L. M., McCabe, C. H., Horacek, T., Papuchis, G., Mautner, B., Corbalán, R., Radley, D. R., & Braunwald, E. (2000) · JAMA · doi:10.1001/jama.284.7.835 · Cited by 3,221
Adjusting for multiple testing—when and how?
Bender, R., & Lange, S. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00314-0 · Cited by 3,168
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
Yusuf, S., Zucker, D. M., Passamani, E. R., Peduzzi, P. N., Takaro, T., Fisher, L. D., Kennedy, J. W., Davis, K. B., Killip, T., Norris, R. M., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91963-1 · Cited by 2,125
Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban
Cannon, C. P., Weintraub, W. S., Demopoulos, L. A., Vicari, R. M., Frey, M. J., Lakkis, N. M., Neumann, F., Robertson, D. H., DeLucca, P. T., DiBattiste, P. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442501 · Cited by 2,093
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67660-x · Cited by 1,858
West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials
(1996) · The Lancet · doi:10.1016/s0140-6736(96)04292-4 · Cited by 1,564

Show all 72 references

Sorted by citations

Items 201–300 of 505

Measuring Representativeness in Clinical Trials
Sanyi, A., Byiringiro, S., Dabiri, S., Jacobson, M., Boyd, A. D., Ogunniyi, M. O., Morris, A. A., Kohn, R. A., Dickert, N. W., Lane-Fall, M. B., et al. (2025) · Circulation · doi:10.1161/circulationaha.124.070299 · Cited by 19
A systematic review of subgroup analyses in randomised clinical trials in cardiovascular disease
Brand, K., Hapfelmeier, A., & Haller, B. (2021) · Clinical Trials · doi:10.1177/1740774520984866 · Cited by 19
Analgesic and Anxiolytic Effects of Virtual Reality During Minor Procedures in an Emergency Department: A Randomized Controlled Study
Bosso, L., Espejo, T., Taffé, P., Caillet‐Bois, D., Christen, T., Berna, C., & Hügli, O. (2022) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2022.04.015 · Cited by 19
Characterizing Treatment Effect Heterogeneity Using Real‐World Data
Thelen, H. E., & Hennessy, S. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3627 · Cited by 19
Inclusion and Analysis of Older Adults in RCTs
van de Water, W., Bastiaannet, E., de Velde, C. J. H. V., & Liefers, G. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1705-x · Cited by 19
Identifying treatment effect heterogeneity in clinical trials using subpopulations of events: STEPP
Lazar, A., Bonetti, M., Cole, B. F., Yip, W., & Gelber, R. D. (2015) · Clinical Trials · doi:10.1177/1740774515609106 · Cited by 19
A Review of Disease Risk Scores and Their Application in Pharmacoepidemiology
Wyss, R., Glynn, R. J., & Gagne, J. J. (2016) · Current Epidemiology Reports · doi:10.1007/s40471-016-0088-2 · Cited by 19
Concerning the “repression” of ω -3 polyunsaturated fatty acids by adepts of evidence-based medicine
Torshin, I. Y., Громова, О. А., & Kobalava, Z. D. (2019) · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · doi:10.17749/2070-4909.2019.12.2.91-114 · Cited by 20
Nortriptyline for pain in knee osteoarthritis: a double-blind randomised controlled trial in New Zealand general practice
Hudson, B., Williman, J. A., Stamp, L. K., Alchin, J. S., Hooper, G. J., Mangin, D. A., Thompson, B. F. L., & Toop, L. J. (2021) · British Journal of General Practice · doi:10.3399/bjgp.2020.0797 · Cited by 19
Anaesthetic depth and delirium: a challenging balancing act
Whitlock, E. L., Gross, E. R., King, C. R., & Avidan, M. S. (2021) · British Journal of Anaesthesia · doi:10.1016/j.bja.2021.08.003 · Cited by 19
Age-treatment subgroup analyses in Cochrane intervention reviews: a meta-epidemiological study
Liu, P., Ioannidis, J. P. A., Ross, J. S., Dhruva, S. S., Luxkaranayagam, A. T., Vasiliou, V., & Wallach, J. D. (2019) · BMC Medicine · doi:10.1186/s12916-019-1420-8 · Cited by 19
Self-citation
Real time continuous glucose monitoring in high‐risk people with insulin‐requiring type 2 diabetes: A randomised controlled trial
Lever, C. S., Williman, J. A., Boucsein, A., Watson, A. S., Sampson, R. S., Sergel‐Stringer, O. T., Keesing, C., Chepulis, L. M., Wheeler, B. J., de Bock, M. I., et al. (2024) · Diabetic Medicine · doi:10.1111/dme.15348 · Cited by 18
Toward Precision in Critical Care Research: Methods for Observational and Interventional Studies
Linck, E. J. G., Goligher, E. C., Semler, M. W., & Churpek, M. M. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006371 · Cited by 18
Incident disability in older adults: prediction models based on two British prospective cohort studies
Nüesch, E., Perel, P., Dale, C. E., Prieto‐Merino, D., Meena Kumari, B., Bowling, A., Ebrahim, S. B. J., & Casas, J. P. (2014) · Age and Ageing · doi:10.1093/ageing/afu159 · Cited by 18
How context can impact clinical trials: a multi-country qualitative case study comparison of diagnostic biomarker test interventions
Haenssgen, M. J., Charoenboon, N., Do, N. T. T., Althaus, T., Zaw, Y. K., Wertheim, H. F. L., & Lubell, Y. (2019) · Trials · doi:10.1186/s13063-019-3215-9 · Cited by 18
Individual differences and evidence-based psychopharmacology
Belmaker, R. H., Bersudsky, Y., & Agam, G. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-110 · Cited by 18
Estimating and presenting hazard ratios and absolute risks from a Cox model with complex nonlinear interactions
Bellavia, A., Melloni, G. E. M., Park, J., Discacciati, A., & Murphy, S. A. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae037 · Cited by 17
Understanding the Value of Individualized Information: The Impact of Poor Calibration or Discrimination in Outcome Prediction Models
Olchanski, N., Cohen, J. T., Neumann, P. J., Wong, J. B., & Kent, D. M. (2017) · Medical Decision Making · doi:10.1177/0272989x17704855 · Cited by 18
Self-citation
A standardized framework for risk-based assessment of treatment effect heterogeneity in observational healthcare databases
Rekkas, A., Klaveren, D. V., Ryan, P. B., Steyerberg, E. W., Kent, D. M., & Rijnbeek, P. R. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00794-y · Cited by 17
Self-citation
Evidence based medicine and patient centered medicine: Some thoughts on their integration
Sacristán, J. A. (2013) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2013.09.002 · Cited by 17
Home-based interventions for black patients with uncontrolled hypertension: a cluster randomized controlled trial
Feldman, P. H., McDonald, M. V., Barrón, Y., Gerber, L. M., & Peng, T. R. (2016) · Journal of Comparative Effectiveness Research · doi:10.2217/cer.15.60 · Cited by 17
Single case designs for early phase behavioral translational research in health psychology.
Epstein, L. H., Bickel, W. K., Czajkowski, S. M., Paluch, R. A., Moeyaert, M., & Davidson, K. W. (2021) · Health Psychology · doi:10.1037/hea0001055 · Cited by 17
The Clinical Research Enterprise
Zilberberg, M. D. (2011) · JAMA · doi:10.1001/jama.2011.104 · Cited by 17
Tailoring treatments using treatment effect modification
Schmidt, A. F., Klungel, O. H., Nielen, M., de Boer, A., Groenwold, R. H. H., & Hoes, A. W. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3965 · Cited by 17
An approach to addressing subpopulation considerations in systematic reviews: the experience of reviewers supporting the U.S. Preventive Services Task Force
Whitlock, E. P., Eder, M. L., Thompson, J. H., Jonas, D. E., Evans, C. V., Guirguis‐Blake, J., & Lin, J. S. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0437-3 · Cited by 18
Implications of Practice Variability
Sessler, D. I. (2020) · Anesthesiology · doi:10.1097/aln.0000000000003162 · Cited by 17
New insight into the analgesic recipe: A cohort study based on smart patient-controlled analgesia pumps records
Song, Y., He, Q., Huang, W., Yang, L., Zhou, S., Xiao, X., Wang, Z., & Huang, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.988070 · Cited by 16
Estimating individualized treatment effects from randomized controlled trials: a simulation study to compare risk-based approaches
Rekkas, A., Rijnbeek, P. R., Kent, D. M., Steyerberg, E. W., & Klaveren, D. V. (2023) · BMC Medical Research Methodology · doi:10.1186/s12874-023-01889-6 · Cited by 16
Self-citation
A Methodological Framework for Meta-analysis and Clinical Interpretation of Subgroup Data: The Case of Major Adverse Cardiovascular Events With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes
Karagiannis, T., Τσάπας, Α., Bekiari, E., Toulis, K. A., & Nauck, M. A. (2024) · Diabetes Care · doi:10.2337/dc23-0925 · Cited by 16
Scientific rigour in psycho‐oncology trials: why and how to avoid common statistical errors
Bell, M. L., Olivier, J., & King, M. T. (2012) · Psycho-Oncology · doi:10.1002/pon.3046 · Cited by 17
A multivariable model to guide the decision for pessary placement to prevent preterm birth in women with a multiple pregnancy: a secondary analysis of the ProTWIN trial
Tajik, P., Monfrance, M., Hooft, J. V. ’., Liem, S. M. S., Schuit, E., Bloemenkamp, K. W. M., Duvekot, J. J., Bijvank, B. N., Franssen, M. T. M., Oudijk, M. A., et al. (2016) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.15855 · Cited by 16
EMMIE and engineering: What works as evidence to improve decisions?
Tilley, N. (2016) · Evaluation · doi:10.1177/1356389016656518 · Cited by 16
Estimating patient-specific treatment advantages in the ‘Treatment for Adolescents with Depression Study’
Foster, S., Mohler‐Kuo, M., Tay, L. S., Hothorn, T., & Seibold, H. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.02.021 · Cited by 16
President's Page: Employing Shared Decision-Making Models to Improve Care and Patient Value: A Cardiovascular Professional Initiative
Brindis, R., & Spertus, J. A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.004 · Cited by 16
Building useful evidence: changing the clinical research paradigm to account for comparative effectiveness research
Greenfield, S., & Kaplan, S. H. (2012) · Journal of Comparative Effectiveness Research · doi:10.2217/cer.12.23 · Cited by 15
The Problem and Promise of Prognosis Research
Rysavy, M. A., & Tyson, J. E. (2016) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2015.4871 · Cited by 15
Understanding physician-level barriers to the use of individualized risk estimates in percutaneous coronary intervention
Decker, C., Garavalia, L. S., Garavalia, B., Gialde, E., Yeh, R. W., Spertus, J. A., & Chhatriwalla, A. K. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.03.027 · Cited by 15
Prevalence and significance of race and ethnicity subgroup analyses in Cochrane intervention reviews
Liu, P., Ross, J. S., Ioannidis, J. P. A., Dhruva, S. S., Vasiliou, V., & Wallach, J. D. (2019) · Clinical Trials · doi:10.1177/1740774519887148 · Cited by 15
Self-citation
Reporting Guidelines
Popham, K., Calo, W. A., Carpentier, M. Y., Chen, N. E., Kamrudin, S. A., Le, Y. L., Skala, K. A., Thornton, L. R., & Mullen, P. D. (2012) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.06.031 · Cited by 15
Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus
Kaasenbrood, L., Poulter, N. R., Sever, P. S., Colhoun, H. M., Livingstone, S. J., Boekholdt, S. M., Pressel, S., Davis, B. R., van der Graaf, Y., & Visseren, F. L. J. (2016) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.001980 · Cited by 15
Sample enrichment for clinical trials to show delay of onset in huntington disease
Paulsen, J. S., Lourens, S. G., Kieburtz, K. D., & Zhang, Y. (2019) · Movement Disorders · doi:10.1002/mds.27595 · Cited by 15
The effect of high protein dosing in critically ill patients: an exploratory, secondary Bayesian analyses of the EFFORT Protein trial
Haines, R. W., Granholm, A., Puthucheary, Z., Day, A. G., Bear, D. E., Prowle, J. R., & Heyland, D. K. (2024) · British Journal of Anaesthesia · doi:10.1016/j.bja.2024.08.033 · Cited by 14
The study of effect moderation in youth suicide-prevention studies
Musci, R. J., Kharrazi, H. H. K., Wilson, R. F., Susukida, R., Gharghabi, F., Zhang, A. W., Wissow, L. S., Robinson, K. A., & Wilcox, H. C. (2018) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-018-1574-2 · Cited by 15
Targeting Efficacy of Spironolactone in Patients with Heart Failure with Preserved Ejection Fraction: The TOPCAT Study
Zhou, H., Zhan, R., Chen, X., Lin, Y.-F., Zhang, S., Zheng, H., Wang, X., Huang, M.-T., Xu, C., Liao, X., et al. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14068 · Cited by 16
Predictors of Long-Term Disease Control and Survival for HER2-Positive Advanced Breast Cancer Patients Treated With Pertuzumab, Trastuzumab, and Docetaxel
Hopkins, A. M., Rowland, A., McKinnon, R. A., & Sorich, M. J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00789 · Cited by 13
Intramuscular progesterone in women with twins and a prior singleton spontaneous preterm birth
Ward, A., Greenberg, V., Valcarcel, B. N., Boelig, R. C., Al‐Kouatly, H. B., & Berghella, V. (2020) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2020.100124 · Cited by 13
An intervention delivered by text message to increase the acceptability of effective contraception among young women in Palestine: study protocol for a randomised controlled trial
McCarthy, O., Wazwaz, O., Jado, I., Leurent, B., Edwards, P., Adada, S., Stavridis, A., & Free, C. (2017) · Trials · doi:10.1186/s13063-017-2191-1 · Cited by 15
Selection of anterior circulation acute stroke patients for mechanical thrombectomy
Sallustio, F., Toschi, N., Mascolo, A. P., Marrama, F., Morosetti, D., Ros, V. D., Gandini, R., Alemseged, F., Koch, G., & Diomedi, M. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09454-2 · Cited by 13
Realizing the Potential of Clinical Risk Prediction Models
Salisbury, A. C., & Spertus, J. A. (2015) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.115.002038 · Cited by 13
Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease — Results from EUROPA
van der Leeuw, J., Oemrawsingh, R. M., van der Graaf, Y., Brugts, J. J., Deckers, J. W., Bertrand, M. E., Fox, K. M., Ferrari, R., Remme, W. J., Simoons, M. L., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.12.046 · Cited by 12
Moneyball, Gambling, and the New Cholesterol Guidelines
Hayward, R. A. (2014) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.114.000876 · Cited by 12
Self-citation
An Intervention Delivered by App Instant Messaging to Increase Acceptability and Use of Effective Contraception Among Young Women in Bolivia: Protocol of a Randomized Controlled Trial
McCarthy, O., Calderon, V. O., Makleff, S., Huaynoca, S., Leurent, B., Edwards, P., Gallardo, J. L., & Free, C. (2017) · JMIR Research Protocols · doi:10.2196/resprot.8679 · Cited by 12
Individualized prediction of the effect of angiotensin receptor blockade on renal and cardiovascular outcomes in patients with diabetic nephropathy
van der Sande, N. G. C., Dorresteijn, J. A. N., Visseren, F. L. J., Dwyer, J. P., Blankestijn, P. J., van der Graaf, Y., & Heerspink, H. L. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12708 · Cited by 12
QUINT: A tool to detect qualitative treatment–subgroup interactions in randomized controlled trials
Doove, L. L., Deun, K. V., Dusseldorp, E., & Mechelen, I. V. (2015) · Psychotherapy Research · doi:10.1080/10503307.2015.1062934 · Cited by 13
A Pharmacist and Health Coach–Delivered Mobile Health Intervention for Type 2 Diabetes: Protocol for a Randomized Controlled Crossover Study
Sharp, L. K., Biggers, A., Perez, R., Henkins, J., Tilton, J., & Gerber, B. S. (2021) · JMIR Research Protocols · doi:10.2196/17170 · Cited by 11
Alzheimer’s Disease and Different Types of Cancer Likelihood: Unveiling Disparities and Potential Protective Effects in a Korean Cohort Study
Kang, H. S., Kim, J. H., Lim, H. S., Kim, J., Noh, H., Choi, H. G., Min, K., Kim, N. Y., & Kwon, M. J. (2023) · Cancers · doi:10.3390/cancers15184615 · Cited by 12
LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ
on behalf of the LEADER Investigators, Rutten, G. E. H. M., Tack, C. J., Pieber, T. R., Çömlekçi, A., Ørsted, D. D., Baeres, F. M. M., Marso, S. P., & Buse, J. B. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0153-5 · Cited by 11
Computational medicine, present and the future: obstetrics and gynecology perspective
Bukowski, R., Schulz, K. W., Gaither, K., Stephens, K. K., Semeraro, D., Drake, J. A., Smith, G. C. S., Cordola, C., Zariphopoulou, T., Hughes, T. J. R., et al. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.08.057 · Cited by 11
A protocol for chronic pain outcome measurement enhancement by linking PROMIS-29 scale to legacy measures and improving chronic pain stratification
Herman, P. M., Edelen, M. O., Rodriguez, A., Hilton, L. G., & Hays, R. D. (2020) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-020-03696-2 · Cited by 11
Quality of biomarker defined subgroups in FDA approvals of PD ‐1/ PD‐L1 inhibitors 2014 to 2020
Kim, M. S., Xu, A., Haslam, A., & Prasad, V. K. (2022) · International Journal of Cancer · doi:10.1002/ijc.33968 · Cited by 11
Individualizing treatment choices using quantitative methods
Pocock, S., Stone, G. W., Mehran, R., & Clayton, T. C. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.08.003 · Cited by 11
Health-related quality-of-life and health-utility reporting in critical care
Lau, V. I., Johnson, J. A., Bagshaw, S. M., Rewa, O. G., Basmaji, J., Lewis, K. A., Wilcox, M. E., Barrett, K. A., Lamontagne, F., Lauzier, F., et al. (2022) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v11.i4.236 · Cited by 10
Telehealth-Based Music Therapy Versus Cognitive Behavioral Therapy for Anxiety in Cancer Survivors: Rationale and Protocol for a Comparative Effectiveness Trial
Liou, K. T., McConnell, K. M., Currier, M. B., Baser, R. E., MacLeod, J., Walker, D. A. H., Casaw, C., Wong, G., Piulson, L., Popkin, K., et al. (2023) · JMIR Research Protocols · doi:10.2196/46281 · Cited by 12
Improving the reporting quality of intervention trials addressing the inter-individual variability in response to the consumption of plant bioactives: quality index and recommendations
Nikolic, M., Konić‐Ristić, A., González‐Sarrías, A., Istas, G., Urpí-Sardà, M., Dall’Asta, M., Monfoulet, L., Cloetens, L., Bayram, B., Tumolo, M. R., et al. (2019) · European Journal of Nutrition · doi:10.1007/s00394-019-02069-3 · Cited by 10
Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working group
Nielsen, S. M., Rasmussen, M. U., Boers, M., van der Windt, D., de Wit, M. P. T., WOODWORTH, T. G., Flurey, C., Beaton, D., Shea, B., Escorpizo, R. S., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217895 · Cited by 10
The Good, the Bad, and the Different: A Primer on Aspects of Heterogeneity of Treatment Effects
Malone, D. C., Hines, L. E., & Graff, J. S. (2014) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2014.20.6.555 · Cited by 10
Field Synopsis of the Role of Sex in Stroke Prediction Models
Paulus, J. K., Lai, L. Y. H., Lundquist, C. M., Daneshmand, A., Buettner, H., Lutz, J. S., Raman, G., Wessler, B. S., & Kent, D. M. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002809 · Cited by 10
Self-citation
Risk-based evaluation of efficacy of rolofylline in patients hospitalized with acute heart failure — Post-hoc analysis of the PROTECT trial
Demissei, B. G., Postmus, D., Liu, L. C. Y., Cleland, J. G. F., O’Connor, C. M., Metra, M., Ponikowski, P. P., Teerlink, J. R., Cotter, G., Davison, B. A., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.08.271 · Cited by 10
Feasibility and efficacy of a decision aid for emergency department patients with suspected ureterolithiasis: protocol for an adaptive randomized controlled trial
Schoenfeld, E. M., Poronsky, K. E., Westafer, L. M., DiFronzo, B. M., Visintainer, P., Scales, C. D., Hess, E. P., & Lindenauer, P. K. (2021) · Trials · doi:10.1186/s13063-021-05140-9 · Cited by 10
Increasing risk-concordant cardiovascular care in diverse health systems: a mixed methods pragmatic stepped wedge cluster randomized implementation trial of shared decision making (SDM4IP)
Ridgeway, J. L., Branda, M. E., Gravholt, D., Brito, J. P., Hargraves, I. G., Hartasanchez, S. A., Leppin, A. L., Gomez, Y. L., Mann, D. M., Nautiyal, V., et al. (2021) · Implementation Science Communications · doi:10.1186/s43058-021-00145-6 · Cited by 10
Finding associations in a heterogeneous setting: statistical test for aberration enrichment
Mezlini, A. M., Das, S., & Goldenberg, A. (2021) · Genome Medicine · doi:10.1186/s13073-021-00864-4 · Cited by 10
Optimal Time of Collapse to Return of Spontaneous Circulation to Apply Targeted Temperature Management for Cardiac Arrest: A Bayesian Network Meta-Analysis
Duan, J., Zhai, Q., Shi, Y., Ge, H., Kang, Z., Du, L., Duan, B., Yu, J., & Ma, Q. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.784917 · Cited by 10
A systematic review of randomized controlled trials and reviews in the management of ventral hernias
Holihan, J. L., Nguyen, D. H., Flores-Gonzalez, J. R., Alawadi, Z. M., Nguyen, M. T., Ko, T. C., Kao, L. S., & Liang, M. K. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.05.009 · Cited by 10
Combining clinical and angiographic variables for estimating risk of target lesion revascularization after drug eluting stent placement
Stolker, J. M., Cohen, D. J., Kennedy, K. F., Pencina, M. J., Arnold, S. V., Kleiman, N. S., & Spertus, J. A. (2016) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2016.12.014 · Cited by 10
Can Observational Studies Approximate RCTs?
Greenfield, S., & Platt, R. G. (2012) · Value in Health · doi:10.1016/j.jval.2012.01.003 · Cited by 10
Vitamin E ameliorates blood cholesterol level and alters gut microbiota composition: A randomized controlled trial
Chen, B., Li, Y., Li, Z., Hu, X., Zhen, H., Chen, H., Nie, C., Hou, Y., Zhu, S., Xiao, L., et al. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.103964 · Cited by 9
EFFICACY-TO-EFFECTIVENESS CLINICAL TRIALS.
Selker, H. P., Gorman, S., & Kaitin, K. I. (2018) · Europe PMC (PubMed Central) · Cited by 9
Acupuncture versus massage for pain in patients living with advanced cancer: a protocol for the IMPACT randomised clinical trial
Romero, S. A. D., Emard, N., Baser, R. E., Panageas, K. S., MacLeod, J., Walker, D. A. H., Barton‐Burke, M., Liou, K. T., Deng, G. E., Farrar, J. T., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-058281 · Cited by 9
Chronic disease diagnosis model based on convolutional neural network and ensemble learning method
Zhou, H., Zhang, P.-Y., Zou, X., Liu, J., & Wang, W. (2023) · Digital Health · doi:10.1177/20552076231198643 · Cited by 9
Methods for Integrating Trials and Non-experimental Data to Examine Treatment Effect Heterogeneity
Lupton‐Smith, C., Chang, T.-H., Nguyen, T. Q., Hong, H., Stefano, L. D., & Stuart, E. A. (2023) · Statistical Science · doi:10.1214/23-sts890 · Cited by 18
Heterogeneous Treatment Effects of Intensive Glycemic Control on Kidney Microvascular Outcomes and Mortality in ACCORD
Charu, V., Liang, J. W., Chertow, G. M., Li, J., Montez‐Rath, M. E., Geldsetzer, P., de Boer, I. H., Tian, L., & Tamura, M. K. (2023) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000272 · Cited by 9
Approaches for hysterectomy and implementation of robot-assisted surgery in benign gynaecological disease: A cost analysis study in a large university hospital
Delameilleure, M., Timmerman, S., Vandoren, C., Ledger, A., Vansteenkiste, N., Dewilde, K., Page, A., Housmans, S., den Bosch, T. V., Deprest, J. A., et al. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.07.060 · Cited by 9
Interpretation of CVD risk predictions in clinical practice: Mission impossible?
Lagerweij, G. R., Moons, K. G. M., de Wit, G. A., & Koffijberg, H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0209314 · Cited by 9
Effect of renal impairment on the efficacy and safety of intra-arterial treatment: A post-hoc analysis of DIRECT-MT study
Hu, W., Shen, H., Tao, C., Zhu, Y., Xu, P., Li, R., Yang, P., Zhang, Y., Li, Z., Zhang, Y., et al. (2021) · International Journal of Stroke · doi:10.1177/17474930211045805 · Cited by 9
A review of the clinical evidence related to early treatment of elevated LDL for cardiovascular primary prevention
Zachrison, K. S., Levine, D. A., & Hayward, R. A. (2015) · BMJ Evidence-Based Medicine · doi:10.1136/ebmed-2015-110170 · Cited by 9
Self-citation
Towards personalised intra-arterial treatment of patients with acute ischaemic stroke: a study protocol for development and validation of a clinical decision aid
Mulder, M. J. H. L., Venema, E., Roozenbeek, B., Broderick, J. P., Yeatts, S. D., Khatri, P., Berkhemer, O. A., Roos, Y. B. W. E. M., Majoie, C. B. L. M., van Oostenbrugge, R. J., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013699 · Cited by 9
The shrinking scope of pragmatic trials: a methodological reflection on their domain of applicability
Pawson, R. (2018) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2018.11.020 · Cited by 9
Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
van der Leeuw, J., Visseren, F. L. J., Woodward, M., van der Graaf, Y., Grobbee, D. E., Harrap, S. B., Heller, S. R., Mancia, G., Marre, M., Poulter, N. R., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-4082-5 · Cited by 8
Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration
Cao, Q., Buskens, E., Hillege, H. L., Jaarsma, T., Postma, M. J., & Postmus, D. (2018) · The European Journal of Health Economics · doi:10.1007/s10198-018-1013-z · Cited by 8
Racial Variation in the Cost-Effectiveness of Chemotherapy for Prostate Cancer
Grabner, M., Onukwugha, E., Jain, R., & Mullins, C. D. (2011) · Journal of Oncology Practice · doi:10.1200/jop.2011.000294 · Cited by 8
An Interoperable Similarity-based Cohort Identification Method Using the OMOP Common Data Model Version 5.0
Chakrabarti, S., Sen, A. K., Huser, V., Hruby, G. W., Rusanov, A., Albers, D. J., & Weng, C. (2017) · Journal of Healthcare Informatics Research · doi:10.1007/s41666-017-0005-6 · Cited by 8
Routine low-dose continuous or nocturnal oxygen for people with acute stroke: three-arm Stroke Oxygen Supplementation RCT
Roffe, C., Nevatte, T. M., Bishop, J. R. B., Sim, J., Peñaloza, C., Jowett, S. M., Ives, N. J., Gray, R. G., Ferdinand, P., & Muddegowda, G. (2018) · Health Technology Assessment · doi:10.3310/hta22140 · Cited by 8
Translating clinical trial results into personalized recommendations by considering multiple outcomes and subjective views
Dagan, N., Cohen-Stavi, C. J., Tsadok, M. A., Leibowitz, M., Hoshen, M. B., Karpati, T., Akriv, A., Gofer, I., Gilutz, H., Podjarny, E., et al. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0156-3 · Cited by 8
An individualized decision between physical therapy or surgery for patients with degenerative meniscal tears cannot be based on continuous treatment selection markers: a marker‐by‐treatment analysis of the ESCAPE study
Noorduyn, J. C. A., van de Graaf, V. A., Willigenburg, N. W., Scholten-Peeters, G. G. M., Mol, B. W., Heymans, M. W., Coppieters, M. W., Poolman, R. W., Scholtes, V. A., Mutsaerts, E. L. A. R., et al. (2022) · Knee Surgery Sports Traumatology Arthroscopy · doi:10.1007/s00167-021-06851-x · Cited by 8
A Systematic Assessment of the Surviving Sepsis Campaign’s Evidence Supporting the Care of Patients with Severe Sepsis on the Wards
Odden, A., Govindan, S., Sheth, J. S., & Iwashyna, T. J. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201502-096le · Cited by 8
Statistical and Methodological Considerations for Randomized Controlled Trial Design in Physical Medicine and Rehabilitation
Thakur, B., Ayers, G. D., Atem, F., DeClercq, J. J., & Jain, N. B. (2023) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000002225 · Cited by 7
Persistence and heterogeneity of the effects of educating mothers to improve child immunisation uptake: Experimental evidence from Uttar Pradesh in India
O’Neill, S., Grieve, R., Singh, K., Dutt, V., & Powell‐Jackson, T. (2024) · Journal of Health Economics · doi:10.1016/j.jhealeco.2024.102899 · Cited by 7
Which stroke patients gain most from intermittent pneumatic compression: further analyses of the CLOTS 3 trial
Dennis, M. S., Graham, C., Smith, J. B. E., Forbes, J., & Sandercock, P. A. (2015) · International Journal of Stroke · doi:10.1111/ijs.12598 · Cited by 7
Thrombectomy for Acute Ischemic Stroke
Wardlaw, J. M., & Dennis, M. S. (2015) · JAMA · doi:10.1001/jama.2015.14674 · Cited by 7
Comparative effectiveness of direct admission and admission through emergency departments for children: a randomized stepped wedge study protocol
Leyenaar, J. K., McDaniel, C. E., Acquilano, S. C., Schaefer, A., BRUCE, M. L., & O’Malley, A. J. (2020) · Trials · doi:10.1186/s13063-020-04889-9 · Cited by 7

Authors: Kent, D. M., Rothwell, P. M., Ioannidis, J. P., Altman, D. G., & Hayward, R. A.
Affiliations: Tufts Medical Center (US)
John Radcliffe Hospital (GB)
University of Oxford (GB)
University of Michigan (US)
Corresponding author: Kent, David M
ORCID: Kent, David M
Rothwell, Peter M
Ioannidis, John PA
Hayward, Rodney A
Venue: Trials
Publisher: Springer Science and Business Media LLC
Published: 2010-08-12
Volume: 11
Issue: 1
Pages: 85-85
ISSN: 1745-6215 (ISSN-L)
DOI: 10.1186/1745-6215-11-85
PMC: PMC2928211
OpenAlex: W2128780239
Cited by: 504
References: 72
Citations by year: 2026: 32 · 2025: 20 · 2024: 33 · 2023: 26 · 2022: 25 · 2021: 43 · 2020: 32 · 2019: 42 · 2018: 36 · 2017: 37 · 2016: 41 · 2015: 31 · 2014: 39 · 2013: 15 · 2012: 28
FWCI: 17.70
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/2.0 (tdm)
Locations: Trials (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders: Pfizer
National Institutes of Health (P60DK20572)
Quality Enhancement Research Initiative
National Institute of Diabetes and Digestive and Kidney Diseases (P60DK020572, P60 DK 20572)
National Institute of Neurological Disorders and Stroke (R01NS062153)
National Center for Research Resources (U54 RR023562)
Topics: Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
Keywords: treatment effect heterogeneity, subgroup analysis, clinical trial reporting, treatment risks and benefits, risk stratification
MeSH terms: Clinical Trials as Topic, Humans, Risk Factors, Therapeutics, Reproducibility of Results, Multivariate Analysis, Risk Assessment, Evidence-Based Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks